Premium
Prenatal course of metaphyseal anadysplasia associated with homozygous mutation in MMP9 identified by exome sequencing
Author(s) -
Sharony R.,
Borochowitz Z.,
Cohen L.,
ShtorchAsor A.,
Rosenfeld R.,
Modai S.,
Reinstein E.
Publication year - 2017
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.13020
Subject(s) - exome sequencing , genetics , mutation , osteochondrodysplasia , biology , fetus , phenotype , prenatal diagnosis , exome , medicine , gene , pregnancy , anatomy
Metaphyseal anadysplasia ( MANDP ) is a rare autosomal recessive form of skeletal dysplasia characterized by normal length at birth and transitory bowing of the legs. Although several families with MANDP have been reported, homozygous mutations in the matrix metalloproteinase type 9 ( MMP9 ) gene have been described in only one consanguineous family, and thus the pre and postnatal phenotypic spectrum is still obscure. A clinically similar but more severe type is caused by autosomal‐dominant inheritance and is caused by mutations in matrix metalloproteinase type 13 gene ( MMP13 ). Here, we report the prenatal and early postnatal course of two affected sib fetuses with early sonographic evidence of long bone shortening and postnatally no metaphyseal changes. Whole‐exome sequencing revealed homozygous mutation in MMP9 in both fetuses suggesting a diagnosis of MANDP . We propose that MANDP should be considered in pregnancies with early prenatal shortening of the long bones without associated finding of lethal skeletal dysplasias. In addition, the finding of homozygous mutation in non‐consanguineous parents of Jewish‐Caucasus ancestry may suggest unawareness of such relation or the occurrence of a founder mutation in this gene.